Illumina published in April. 15 that $100 million will be invested to a new asset management company——Illumina Venture. Former senior vice president Nicholas Naclerio will take up the post of new company` s CEO.

The funds from most of limited partners have been used for early investment by Illumina, and there will be $100 million flexible capital pool in future 10 years.

According to the report, the investing projects from Illumina Venture mainly focus on the nucleotide sequencing developing, genetic product developing as well as these early entrepreneurial firms utilizing genomics to improve health. Jay Flatley, president of Illumina` s board of directors and CEO expressed that risk investing fund inside the company promotes the strategic insight effectively and enhances the industrial sales channel for the key technology, which is an effective way to create values for share holders.

Before 2 years, Illumina established a project named “Startup accelerator” which helped many entrepreneurial firms for application of high-flux sequencing technology, again in last Aug., the company invested the second round for this item.